Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2024 Dec 31;20(1):2343544.
doi: 10.1080/21645515.2024.2343544. Epub 2024 Apr 24.

Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patients

Federica Baffetta  1 , Cecilia Buonsanti  1 , Luca Moraschini  1 , Susanna Aprea  1 , Martina Canè  2 , Stefano Lombardi  1 , Mario Contorni  1 , Simona Rondini  3 , Ashwani Kumar Arora  3 , Monia Bardelli  1 , Oretta Finco  1 , Davide Serruto  1 , Silvia Rossi Paccani  1
Affiliations
Clinical Trial

Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patients

Federica Baffetta et al. Hum Vaccin Immunother. .

Abstract

Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory illness in older adults. A major cause of COPD-related morbidity and mortality is acute exacerbation of COPD (AECOPD). Bacteria in the lungs play a role in exacerbation development, and the most common pathogen is non-typeable Haemophilus influenzae (NTHi). A vaccine to prevent AECOPD containing NTHi surface antigens was tested in a clinical trial. This study measured IgG and IgA against NTHi vaccine antigens in sputum. Sputum samples from 40 COPD patients vaccinated with the NTHi vaccine were collected at baseline and 30 days after the second dose. IgG and IgA antibodies against the target antigens and albumin were analyzed in the sputum. We compared antibody signals before and after vaccination, analyzed correlation with disease severity and between sputum and serum samples, and assessed transudation. Antigen-specific IgG were absent before vaccination and present with high titers after vaccination. Antigen-specific IgA before and after vaccination were low but significantly different for two antigens. IgG correlated between sputum and serum, and between sputum and disease severity. Sputum albumin was higher in patients with severe COPD than in those with moderate COPD, suggesting changes in transudation played a role. We demonstrated that immunization with the NTHi vaccine induces antigen-specific antibodies in sputum. The correlation between IgG from sputum and serum and the presence of albumin in the sputum of severe COPD patients suggested transudation of antibodies from the serum to the lungs, although local IgG production could not be excluded.Clinical Trial Registration: NCT02075541.

Keywords: COPD exacerbations; COPD pathology; bacterial infection; infection control; respiratory infection.

Plain language summary

What is the context? Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory illness in older adults and the third leading cause of death worldwide.One bacterium in the lungs, non-typeable Haemophilus influenzae (NTHi), is responsible for acute exacerbation of the disease, characterized by an increase in airway wall inflammation and symptoms, leading to high morbidity and mortality.A vaccine targeting NTHi was previously developed but did not show efficacy in reducing exacerbations in COPD patients, probably because the vaccine did not elicit an immune response in the lung mucosae, where the bacteria are located.What is the impact? Parenteral immunization with new vaccines targeting NTHi is able to elicit immune defense at the level of lung mucosae.Now that antibodies can be measured in sputum, new vaccines against COPD exacerbations or other lung infections can be tested for efficacy in the actual target tissue.Also, lung immunity against specific pathogens can now be tested.What is new? We determined that antigen-specific antibodies were present in the lungs after vaccination; these were assessed in sputum after vaccination with NTHi surface antigens.NTHi-specific IgG were present in the lungs and appeared to have arrived there primarily by transudation, a type of leakage from the serum to the lung mucosae.Transudation appeared to be stronger in severe than in moderate COPD patients.

PubMed Disclaimer

Conflict of interest statement

AKA, CB, DS, FB, LM, MB, MCo, OF, SA, SL, SR, and SRP are employed by GSK. AKA, LM, MB, MCo, SR, and SRP hold shares in GSK. The authors declare no other financial and non-financial relationships and activities. MCa declare no financial and non-financial relationships and activities and no conflicts of interest.

Figures

Figure 1.
Figure 1.
IgG response pre-vaccination vs post-vaccination.
Figure 2.
Figure 2.
IgA response pre-vaccination vs post-vaccination.
Figure 3.
Figure 3.
Correlation between IgG in serum and IgG in sputum.
Figure 4.
Figure 4.
Correlation of disease severity with antigen-specific antibodies and sputum/serum ratio.
Figure 5.
Figure 5.
Transudation was detected in sputum from severe COPD patients.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. World Health Organization . The top 10 causes of death; [accessed 2023 Feb 13] https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
    1. MacNee W. ABC of chronic obstructive pulmonary disease. Pathology, pathogenesis, and pathophysiology. BMJ. 2006;332(7551):1202–9. doi:10.1136/bmj.332.7551.1202. - DOI
    1. MacNee W, Tuder RM. New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proc Am Thorac Soc. 2009;6(6):527–31. doi:10.1513/pats.200905-027DS. - DOI - PubMed
    1. Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–52. doi:10.1136/thorax.57.10.847. - DOI - PMC - PubMed
    1. European Respiratory Society . European Lung White Book. Respiratory Health and Disease in Europe. Sheffield, UK: European Respiratory Society; 2013.

Publication types

MeSH terms

Associated data